Wolfe R - Search Results

1

Attainment of low-density lipoprotein cholesterol goals in statin treated patients: Real-world evidence from Australia.

Talic S, Marquina C, Zomer E, Ofori-Asenso R, Petrova M, Vargas-Torres S, Abushanab D, Wolfe R, Lybrand S, Thomson D, Stratton G, Liew D, Ademi Z. Talic S, et al. Among authors: wolfe r. Curr Probl Cardiol. 2022 Jul;47(7):101068. doi: 10.1016/j.cpcardiol.2021.101068. Epub 2021 Nov 21. Curr Probl Cardiol. 2022. PMID: 34818528 Review.

2

Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factors.

Beauchamp A, Peeters A, Wolfe R, Turrell G, Harriss LR, Giles GG, English DR, McNeil J, Magliano D, Harrap S, Liew D, Hunt D, Tonkin A. Beauchamp A, et al. Among authors: wolfe r. J Epidemiol Community Health. 2010 Jun;64(6):542-8. doi: 10.1136/jech.2009.094516. Epub 2009 Oct 12. J Epidemiol Community Health. 2010. PMID: 19825786

3

The economic implications of treating atherothrombotic disease in Australia, from the government perspective.

Ademi Z, Liew D, Hollingsworth B, Wolfe R, Steg GP, Bhatt DL, Reid CM; REACH Registry Investigators. Ademi Z, et al. Among authors: wolfe r. Clin Ther. 2010 Jan;32(1):119-32; discussion 106-7. doi: 10.1016/j.clinthera.2010.01.009. Clin Ther. 2010. PMID: 20171418

4

Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes.

Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Reid CM, Krum H. Campbell DJ, et al. Among authors: wolfe r. Intern Med J. 2013 Feb;43(2):137-43. doi: 10.1111/j.1445-5994.2012.02927.x. Intern Med J. 2013. PMID: 22909211

5

N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).

McGrady M, Reid CM, Shiel L, Wolfe R, Boffa U, Liew D, Campbell DJ, Prior D, Krum H. McGrady M, et al. Among authors: wolfe r. Eur J Heart Fail. 2013 May;15(5):573-80. doi: 10.1093/eurjhf/hft001. Epub 2013 Jan 20. Eur J Heart Fail. 2013. PMID: 23338855 Free article.

6

NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).

McGrady M, Reid CM, Shiel L, Wolfe R, Boffa U, Liew D, Campbell DJ, Prior D, Stewart S, Krum H. McGrady M, et al. Among authors: wolfe r. Int J Cardiol. 2013 Oct 30;169(2):133-8. doi: 10.1016/j.ijcard.2013.08.089. Epub 2013 Sep 7. Int J Cardiol. 2013. PMID: 24080362

7

Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve.

Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Reid CM, Krum H. Campbell DJ, et al. Among authors: wolfe r. J Hypertens. 2014 Nov;32(11):2158-65; discussion 2165. doi: 10.1097/HJH.0000000000000320. J Hypertens. 2014. PMID: 25275245

8

SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace.

Boffa U, McGrady M, Reid CM, Shiel L, Wolfe R, Liew D, Campbell DJ, Stewart S, Krum H. Boffa U, et al. Among authors: wolfe r. Aust Health Rev. 2017 May;41(2):121-126. doi: 10.1071/AH15107. Aust Health Rev. 2017. PMID: 27096227

9

Risk factor management in a contemporary Australian population at increased cardiovascular disease risk.

Campbell DJ, Coller JM, Gong FF, McGrady M, Prior DL, Boffa U, Shiel L, Liew D, Wolfe R, Owen AJ, Krum H, Reid CM. Campbell DJ, et al. Among authors: wolfe r. Intern Med J. 2018 Jun;48(6):688-698. doi: 10.1111/imj.13678. Intern Med J. 2018. PMID: 29136331

10

Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry.

Chin KL, Wolfe R, Reid CM, Tonkin A, Hopper I, Brennan A, Andrianopoulos N, Duffy SJ, Clark D, Ajani A, Liew D; Melbourne Interventional Group (MIG). Chin KL, et al. Among authors: wolfe r. Cardiovasc Drugs Ther. 2018 Feb;32(1):57-64. doi: 10.1007/s10557-018-6769-y. Cardiovasc Drugs Ther. 2018. PMID: 29349644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,966 results

Search Page